Meridian Bioscience Inc (VIVO) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Meridian Bioscience Inc   (NASDAQ: VIVO)


Meridian Bioscience Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Meridian Bioscience Inc's ROI in the first quarter of 2023?
Meridian Bioscience Inc recorded a cumulative net loss of $-3 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -0.68%.

Within the Healthcare sector 250 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2022 from 0 to 686.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
I. Quarter		 (Sep 30 2022)
IV. Quarter		 (Jun 30 2022)
III. Quarter		 (Mar 31 2022)
II. Quarter		 (Dec 31 2021)
I. Quarter
Y / Y Investment Change TTM -2.58 % 2.5 % 8.07 % 10.8 % 17.52 %
Y / Y Net Income Change TTM - -40.54 % -32.96 % 17.59 % 123.94 %
Investment (TTM) in Millions 366 393 406 415 409
Return On Investment (TTM) -0.68 % 10.46 % 10.56 % 15.14 % 14.79 %
VIVO's Overall Ranking # 686 # 0 # 1040 # 709 # 125
Seq. Investment Change TTM -2.63 % -1.29 % -0.26 % 1.63 % 2.44 %
Seq. Net Income Change TTM - -2.19 % -30.45 % 4.09 % -16.02 %
Net Income (TTM) in Millions -3 42 43 62 60

VIVO Company Profile >> Back to VIVO Roi Comparisons >> See Annual VIVO Return On Investment



Return On Investment VIVO's Ranking
Within: No.
Industry # 3
Sector # 251
Overall # 686

Return On Investment Statistics
High Average Low
25.79 %
16.45 %
-0.68 %
(Jun 30 2013)   (Dec 31 2022)







Financial Statements
Meridian Bioscience Inc's I. Quarter Investments $ 366 Millions VIVO's Balance sheet
Meridian Bioscience Inc's I. Quarter Income $ -30 Millions Quarterly VIVO's Income Statement
VIVO's Income by Division See VIVO's Income by Division


VIVO Annual Return On Investment (Sep 30 2022)
2022		 (Sep 30 2021)
2021		 (Sep 30 2020)
2020		 (Sep 30 2019)
2019		 (Sep 30 2018)
2018
Total Investments in Millions 393 403 353 302 225
Y / Y Investment Growth -2.26 % 14.13 % 16.78 % 34.51 % 0.06 %
Net Income in Millions 42 71 46 24 24
Y / Y Net Income Growth -40.54 % 54.61 % 89.43 % 2.23 % 10.63 %
Annual Return On Investment 10.79 % 17.74 % 13.09 % 8.07 % 10.62 %


Annual Roi Comment
In the fiscal year 2022 ROI decreased relative to the previous year to 10.79 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VIVO's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VIVO's Competitors
Subscribers only: Roi for Meridian Bioscience Inc's Suppliers
Subscribers only: Return On Investment for VIVO's Customers

Other Ratios
VIVO's Roa VIVO's Inventory Turnover Ratio VIVO's Growth Rates VIVO's Dividend Statistics
VIVO's Profitability Ratios VIVO's Asset Turnover Ratio VIVO's Dividend Growth
VIVO's Roe VIVO's Valuation Ratios VIVO's Financial Strength Ratios VIVO's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-26T06:55:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.